Literature DB >> 24767861

TNFAIP8 overexpression is associated with platinum resistance in epithelial ovarian cancers with optimal cytoreduction.

Tianbo Liu1, Bairong Xia1, Yanhong Lu2, Ye Xu1, Ge Lou3.   

Abstract

Here, we correlated tumor necrosis factor α-induced protein 8 (TNFAIP8) messenger RNA (mRNA) expression with clinicopathological parameters and investigated the involvement of TNFAIP8 overexpression in platinum resistance of epithelial ovarian cancer (EOC). The status of TNFAIP8 protein was evaluated by Western blot analysis (n = 25) and immunohistochemistry (n = 134). TNFAIP8 mRNA expression was assessed with real-time polymerase chain reaction in fresh frozen EOC tissues (n = 40). TNFAIP8 overexpression at both mRNA and protein levels in platinum-resistant disease was clearly higher than that in platinum-sensitive disease (P < .05). Platinum resistance was independently correlated with residual tumor size (P = .025), ascites (P = .027), and TNFAIP8 overexpression (P = .003). In particular, TNFAIP8 overexpression was correlated with platinum resistance in EOCs with optimal cytoreduction (P = .001). TNFAIP8 mRNA expression was strongly associated with residual tumor size (P = .019). In conclusion, our findings indicate that TNFAIP8 overexpression is an independent predictor of platinum resistance and may be a potential biomarker for targeted therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelial ovarian cancer; Optimal cytoreduction; Platinum resistance; Tumor necrosis factor α–induced protein 8

Mesh:

Substances:

Year:  2014        PMID: 24767861     DOI: 10.1016/j.humpath.2014.02.005

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

1.  Genome-wide analysis of androgen receptor binding sites in prostate cancer cells.

Authors:  Yue Cheng; Pan Yu; Xiuzhi Duan; Chunhua Liu; Siqi Xu; Yuhua Chen; Yunnian Tan; Yun Qiang; Junfang Shen; Zhihua Tao
Journal:  Exp Ther Med       Date:  2015-04-03       Impact factor: 2.447

2.  The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression.

Authors:  Julie M Lowe; Thuy-Ai Nguyen; Sara A Grimm; Kristin A Gabor; Shyamal D Peddada; Leping Li; Carl W Anderson; Michael A Resnick; Daniel Menendez; Michael B Fessler
Journal:  Cell Death Differ       Date:  2016-11-11       Impact factor: 15.828

3.  MicroRNA-9 inhibits the gastric cancer cell proliferation by targeting TNFAIP8.

Authors:  Hong-Yu Gao; Fu-Chun Huo; Hai-Yan Wang; Dong-Sheng Pei
Journal:  Cell Prolif       Date:  2017-01-27       Impact factor: 6.831

4.  TNFAIP8 variants as potential epidemiological and predictive biomarkers in ovarian cancer.

Authors:  Hongyu Gao; Zhiran Zhang; Liangliang Jiang; Lei Zhang; Ling Qin; Tianbo Liu; Shanshan Yang
Journal:  Cancer Cell Int       Date:  2020-08-17       Impact factor: 5.722

5.  A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction.

Authors:  Jessica A Monteith; Hestia Mellert; Morgan A Sammons; Laudita A Kuswanto; Stephen M Sykes; Lois Resnick-Silverman; James J Manfredi; Shelley L Berger; Steven B McMahon
Journal:  Mol Oncol       Date:  2016-06-07       Impact factor: 6.603

6.  In Silico Analysis of Tumor Necrosis Factor α-Induced Protein 8-Like-1 (TIPE1) Protein.

Authors:  Pei Shen; Hong Zhang; Zhaoliang Su; Shengjun Wang; Huaxi Xu
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  TNFAIP8 promotes prostate cancer cell survival by inducing autophagy.

Authors:  Suryakant Niture; Malathi Ramalinga; Habib Kedir; Dorrelyn Patacsil; Samiksha S Niture; James Li; Haresh Mani; Simeng Suy; Sean Collins; Deepak Kumar
Journal:  Oncotarget       Date:  2018-06-01

8.  TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.

Authors:  Ying Xing; Yuechao Liu; Tianbo Liu; Qingwei Meng; Hailing Lu; Wei Liu; Jing Hu; Chunhong Li; Mengru Cao; Shi Yan; Jian Huang; Ting Wang; Li Cai
Journal:  Cell Commun Signal       Date:  2018-07-31       Impact factor: 5.712

Review 9.  Tumor Necrosis Factor-α Induced Protein 8: Pathophysiology, Clinical Significance, and Regulatory Mechanism.

Authors:  Lei Zhang; Ran Liu; Ying-Yi Luan; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2018-03-10       Impact factor: 6.580

10.  TIPE1 function as a prognosis predictor and negative regulator of lung cancer.

Authors:  Xiaocheng Wu; Yunmiao Ma; Ji Cheng; Xia Li; Hui Zheng; Li Jiang; Renjie Zhou
Journal:  Oncotarget       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.